Drug Design, Development, and Delivery: An Interdisciplinary Course on Pharmaceuticals

Authors

  • Mark R. Prausnitz Georgia Institute of Technology
  • Andreas S. Bommarius Georgia Institute of Technology

Abstract

We developed a new interdisciplinary course on pharmaceuticals to address needs of undergraduate and graduate students in chemical engineering and other departments. This course introduces drug design, development, and delivery in an integrated fashion that provides scientific depth in context with broader impacts in business, policy, and ethics. Emphasis on case studies of real drug products, combined with in-class student project presentations, employs active learning with direct relevance to industrial practice and daily life.

Author Biographies

Mark R. Prausnitz, Georgia Institute of Technology

Mark Prausnitz is a professor of chemical and biomolecular engineering at the Georgia Institute of Technology. He was educated at Stanford University (B.S., ’88) and M.I.T. (Ph.D., ’94). Prof. Prausnitz currently teaches classes on pharmaceuticals, mass and energy balances, and technical communication. His research addresses novel biophysical mechanisms to improve drug, gene, and vaccine delivery using engineering technologies.

Andreas S. Bommarius, Georgia Institute of Technology

Andreas Bommarius is a professor in the Schools of Chemical & Biomolecular
Engineering and Chemistry/Biochemistry at the Georgia Institute of Technology. After his Ph.D. at MIT in 1989, he headed the Enzyme Catalysis lab and pilot plant of Degussa in Wolfgang, Germany, until 2000. He teaches classes in pharmaceuticals, heat and mass transfer, bioprocess engineering, biocatalysis, and process design. His research interests focus on biocatalysis and bioprocessing, more specifically on the development of novel biocatalysts, protein stability, and data-driven protein engineering.

Downloads

Published

2011-01-01

Issue

Vol. 45 No. 1 (2011): Winter 2011

Section

Manuscripts